Dear Colleagues,
On behalf of the Ministry of Labour, Health and Social Affairs of Georgia I would like to send you the questionnaire and the survey information approval letter.signed by the Deputy Minister, Mr. Zaza Sopromadze.
Please Confirm the receipt of this email.
Best regards,
Mariana Mkurnali
Executive Department
Head of International Relations Division
Ministry of Labour, Health and Social Affairs of Georgia
144 Tsereteli ave., 0159 Tbilisi, Georgia
Cell phone: +995 599490942
E-mail: mmkurnali@moh.gov.ge
მარიანა მკურნალი
საერთაშორისო ურთიერთობებისა და აპარატის საქმისწარმოების სამმართველოს უფროსი
ადამიანური რესურსების მართვისა და საერთაშორისო ურთიერთობების დეპარტამენტი
საქართველოს შრომის, ჯანმრთელობისა და სოციალური დაცვის სამინისტრო
აკ. წერეთლის გამზირი 144, თბილისი, საქართველო, 0159
მობ: +995 599 490942
From: Tea Jikia [mailto:tjikia@moh.gov.ge]
Sent: 10 July, 2017 13:57
To: Mariana Mkurnali
Subject: Fwd: FW: Survey assessing the implementation barriers for some new drugs for treatment of multidrug-resistant TB (MDR-TB)
-----Original Message-----
From: POLISHCHUK, Olexandr <polishchuko@who.int>
To: Tea Jikia (tjikia@moh.gov.ge) <tjikia@moh.gov.ge>, Tea Jikia <teajikia77@yahoo.com>
Date: Sun, 9 Jul 2017 07:53:27 +0000
Subject: FW: Survey assessing the implementation barriers for some new drugs for treatment of multidrug-resistant TB (MDR-TB)
Hope you are beck well.
Please find attached all papers with regards to the survey.
They were sent according to the WHO protocol and a delay may occur due to administrative reasons.
Please help to fill the questionnaire in and send it to us with the survey information approval letter.
Thank you in advance.
With best regards
Olexandr
From: BOYAKHCHYAN, Varduhi On Behalf Of KLUGE, Hans Henri P.
Sent: 29 June 2017 15:06
To: 'nberdzuli@moh.gov.ge'; nkochiashvili@moh.gov.ge
Cc: 'nana@moh.gov.ge'; 'geomission.geneva@mfa.gov.ge'; 'Copenhagen.emb@mfa.gov.ge'; 'niels.scott@undp.org'; 'registry.ge@undp.org'; IVANUSA, Marijan; IVANUSA, Marijan
Subject: Survey assessing the implementation barriers for some new drugs for treatment of multidrug-resistant TB (MDR-TB)
Dear Colleagues,
This is to inform you that the World Health Organization Global TB Programme, in collaboration with the World Health Organization Regional Office for Europe, conduct a survey assessing the implementation barriers for some new drugs for treatment of multidrug-resistant TB (MDR-TB), namely bedaquiline (bdq) and delamanid (dlm). The survey focuses on medicines regulatory issues for the registration of these two products.
Invitation to participate in the survey, scope and purposes, survey questionnaire and survey information approval are attached herewith.
The survey questionnaire in English version is 4,5 pages only and is reasonably easy to be filled in.
We would highly appreciate your support to our project and we kindly ask to send the filled in questionnaire and survey information approval signed by the Ministry before the 15 July 2017 as explained in the invitation letter.
Yours sincerely,
Dr Hans Kluge
Director, Division of Health Systems and Public Health